AKT1 and cancer: In addition, several studies have shown that the PI3K/AKT pathway enhances the biological basis of cancer through ABCG2, and its activation may reduce the response to chemotherapy drugs and enhance drug efflux (Lampada et al. 2017; Tazzari et al. 2007).